Work

Combined systemic and intralesional 9‐valent human papillomavirus vaccine for recurrent squamous cell carcinoma in situ of the penis

Year: 2023

Type: article

Abstract: Figure 2 Penile SCCIS prior to and after intralesional 9-valent human papillomavirus vaccine.(a,b) Biopsy-proven recurrent SCCIS on the penis presenting as an eroded pink plaque prior to the first intralesional 9-valent HPV vaccine.(c,d) Complete tumor regression was observed after four doses of the 9-valent HPV vaccine delivered intralesionally

Source: International Journal of Dermatology

DOI: 10.1111/ijd.16880

Authors: Anna J. Nichols, W. Austin Wyant, Sonali Nanda, Evangelos V. Badiavas, Harold S. Rabinovitz, Robert S. Kirsner, Tim Ioannides

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, University of Oklahoma Medical Center, University of Oklahoma, Augusta University

Language: English

Topic: Genital Health and Disease

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388863376

FWCI: 0.724

Cites: 5

Cited by: 3

Related to: 10